Press Releases
27 February 2020
BRISBANE, Australia and SEATTLE, Feb. 27, 2020 /PRNewswire/ -- Immunexpress, Pty Ltd & Inc., a molec
Read more...27 February 2020
BOSTON, Feb. 27, 2020 /PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A. focused on research and development of treatments for rare and ultra-rare disorders, today announced its support for Rare Disease Day 2020 and highlighted the company's continued commitment to understanding and addressing the needs of patients living wit
Read more...27 February 2020
ZURICH, Feb. 27, 2020 /PRNewswire/ -- Neurimmune AG, the discoverer of aducanumab and cinpanemab, announced today enrollment of the first patient in a Phase 1 clinical trial to evaluate NI006 in transthyretin amyloid cardiomyopathy (ATTR cardiomyopathy).
Read more...27 February 2020
NASHVILLE, Tenn., Feb. 27, 2020 /PRNewswire/ -- Promises Behavioral Health ("Promises"), a growing national provider of comprehensive behavioral health, substance use disorder treatment and related services, today announced that its Chairman, Rob Waggener, will take on the added responsibilities of interim Chief Executive Officer. Mr.
Read more...27 February 2020
HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan and Upjohn,
Read more...27 February 2020
LEXINGTON, Mass., Feb. 27, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into a common stock purchase agreement (the "Agreement") of up to $30 million with Aspire Capital Fund, LLC ("Aspire Capita
Read more...27 February 2020
SALT LAKE CITY, Feb. 27, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced interim blinded data from the VISIONARY-MS Phase 2 study demonstrating median improvements in functional scores in the enrolled population of patients with relapsing multiple sclerosis (MS). The interim results will be featured in
Read more...27 February 2020
SAN DIEGO, Feb. 27, 2020 /PRNewswire/ -- IQ4I Research & Consultancy published a new report on "Medical Device Contract Manufacturing (MDCM) Global Market – Forecast To 2026."
Read more...27 February 2020
ST. LOUIS, Feb. 27, 2020 /PRNewswire/ -- There's a good chance that a patient of Mercy's Dr. Charles Albritton, a Leap Day baby and an OB-GYN, could end up having a baby this Leap Day, Feb. 29. Because the special day occurs only every four years, a Leap Day birthday is a rarity. Of more than 45,000 employees, Dr. Albritton and 33 others are
Read more...27 February 2020
ATLANTA, Feb. 27, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) (the "Company"), brings to the attention of its shareholders a Letter to Stakeholders and Investo
Read more...
